Changes

From Biolecture.org

Rosetta Genomics

115 bytes added, 13:03, 16 January 2009
no edit summary
more <br />
<br />
<font size="4"><strong>Rosetta Genomics MicroRNA-based Therapeutics </strong></font>&nbsp;<br />
<br />
We They seek to establish relationships with leading pharmaceutical companies and research institutions to develop microRNA-based products. &nbsp;<br />In 2006, we they joined forces with [[Isis Pharmaceuticals Inc. ]] to develop a drug for liver cancer. &nbsp;<br />With Isis, we have recently initiated in vivo studies on several microRNA targets, that, when inhibited, lead to a decrease in liver cancer cell growth. more <br /><br />About the Rosetta Stone <br />
<br />
<font size="4">About the Rosetta Stone <br />
</font><br />
Rosetta Genomics takes its name from the Rosetta Stone, a large ancient stone engraving discovered by Napoleon&rsquo;s troops in 1799 in a small village on the Nile Delta. The Rosetta Stone includes sections of carved text presented in three different ancient scripts, including ancient Egyptian Hieroglyphics. For the first time, thanks to the Rosetta Stone, researchers were able to decipher ancient Egyptian Hieroglyphics, thereby opening the Ancient World to modern eyes. <br />
As the Rosetta Stone helped to decode the meaning of ancient texts, so Rosetta Genomics is dedicated to unlocking the mysteries of microRNA, and more generally of the genetic code. We believe our efforts will help many others to understand this new &ldquo;language&rdquo; in healthcare and introduce a new generation of diagnostic and therapeutic products to improve human health. <br />
<br />
<br />
Retrieved from "https://Biolecture.org/Special:MobileDiff/2358"

Navigation menu